Standard Biotools (LAB) Non-Current Debt (2010 - 2023)

Standard Biotools (LAB) has 5 years of Non-Current Debt data on file, last reported at $3.4 million in Q4 2023.

• Quarterly Non-Current Debt fell 58.34% year-over-year to $3.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $3.4 million (down 58.34% YoY) and the FY2023 annual result came in at $3.4 million, down 58.34% from the prior year.
• Non-Current Debt slipped to $3.4 million in Q4 2023 per LAB's latest filing, from $4.6 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $10.2 million in Q2 2022 and bottomed at $3.4 million in Q4 2023.
• The 3-year median for Non-Current Debt is $8.8 million (2022), against an average of $7.9 million.
• The widest annual swing landed in 2022, when Non-Current Debt decreased 6.07%; it then tumbled 58.34% in 2023.
• Tracing LAB's Non-Current Debt over 3 years: stood at $10.0 million in 2021, then dropped by 18.46% to $8.2 million in 2022, then slumped by 58.34% to $3.4 million in 2023.
• Per Business Quant, the three latest LAB Non-Current Debt figures stand at $3.4 million (Q4 2023), $4.6 million (Q3 2023), and $5.8 million (Q2 2023).

Peer Comparison